Citi keeps a Neutral rating on Fortrea (FTRE) with a $6 price target after adding a “downside 90-day short-term view” on the shares. Citi is cautious on Fortrea, citing the softer demand environment amid biotech delays in funding.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FTRE: